Pilot Study Characterizing a Single Pooled Preparation of Equine Platelet Lysate for Nebulization in the Horse

Overview

Journal Front Vet Sci

Specialty Veterinary Medicine

Date 2024 Dec 27

PMID 39726585

Authors

Patricia Egli

Lindsey Boone

Laura Huber

Courtney Higgins

Pankaj P Gaonkar

Justine Arrington

Maria C Naskou

John Peroni

Julie Gordon

Kara M Lascola

Affiliations

Soon will be listed here.

Abstract

Introduction: Platelet lysate (PL) demonstrates antimicrobial and anti-inflammatory properties offering potential for treatment of bacterial pneumonia in horses. It remains unknown whether nebulization is suitable for PL administration in horses. This pilot study characterized particle size and flow rate of pooled equine PL (single preparation) nebulized using an equine-specific nebulizer (Flexivent).

Methods: Protein composition and antimicrobial activity were compared before and after nebulization. Protein composition was evaluated according to growth factor, antimicrobial peptide and cytokine concentrations and proteomic analysis. To evaluate antimicrobial activity, bacterial growth inhibition [maximum growth (μmax); carrying capacity (K)] were determined for subsp and (WT and MDR) using pre- and post-nebulized PL concentrations of 50%.

Results: Flow rate and median particle size were 0.8 ml/min and 4.991 μm with 52% of particles ≤ 5 μm. Differences in PL protein composition were detected with nebulization. For and , nebulization did not alter effect of PL on growth parameters. PL treatments decreased K for ( = 0.009) compared to BHI. For K was increased post- vs. pre-nebulization (WT and MDR) and μmax increased pre- vs, post-nebulization (MDR). PL treatments increased K and μmax for MDR and μmax for WT compared to BHI ( ≤ 0.05).

Conclusion: Nebulization of PL is technically feasible. The results of this study support further investigation to better characterize the effect of nebulization on PL and its suitability for nebulization in horses.

References

Sumner S, Naskou M, Thoresen M, Copland I, Peroni J . Platelet lysate obtained via plateletpheresis performed in standing and awake equine donors. Transfusion. 2017; 57(7):1755-1762. DOI: 10.1111/trf.14124. View

Valtetsiotis K, Di Martino A, Brunello M, DAgostino C, Poluzzi R, Ferri R . Platelet lysate for the treatment of osteoarthritis: a systematic review of preclinical and clinical studies. Musculoskelet Surg. 2024; 108(3):275-288. PMC: 11371856. DOI: 10.1007/s12306-024-00827-z. View

Jeyaraman M, Muthu S, Khanna M, Jain R, Anudeep T, Muthukanagaraj P . Platelet lysate for COVID-19 pneumonia-a newer adjunctive therapeutic avenue. Stem Cell Investig. 2021; 8:11. PMC: 8256133. DOI: 10.21037/sci-2020-042. View

Palma E, Tilocca B, Roncada P . Antimicrobial Resistance in Veterinary Medicine: An Overview. Int J Mol Sci. 2020; 21(6). PMC: 7139321. DOI: 10.3390/ijms21061914. View

Morrell C, Aggrey A, Chapman L, Modjeski K . Emerging roles for platelets as immune and inflammatory cells. Blood. 2014; 123(18):2759-67. PMC: 4007605. DOI: 10.1182/blood-2013-11-462432. View

Steinman A, Navon-Venezia S . Antimicrobial Resistance in Horses. Animals (Basel). 2020; 10(7). PMC: 7401552. DOI: 10.3390/ani10071161. View

Le N, Han C, Delila L, Nebie O, Chien H, Wu Y . Proteomics of human platelet lysates and insight from animal studies on platelet protein diffusion to hippocampus upon intranasal administration. APL Bioeng. 2024; 8(2):026111. PMC: 11080963. DOI: 10.1063/5.0196553. View

Bordin A, Huber L, Sanz M, Cohen N . Rhodococcus equi foal pneumonia: Update on epidemiology, immunity, treatment and prevention. Equine Vet J. 2022; 54(3):481-494. DOI: 10.1111/evj.13567. View

Naskou M, Sumner S, Berezny A, Copland I, Peroni J . Fibrinogen-Depleted Equine Platelet Lysate Affects the Characteristics and Functionality of Mesenchymal Stem Cells. Stem Cells Dev. 2019; 28(23):1572-1580. DOI: 10.1089/scd.2019.0070. View

10.

Shariati A, Moradabadi A, Ghaznavi-Rad E, Dadmanesh M, Komijani M, Nojoomi F . Investigation into antibacterial and wound healing properties of platelets lysate against Acinetobacter baumannii and Klebsiella pneumoniae burn wound infections. Ann Clin Microbiol Antimicrob. 2021; 20(1):40. PMC: 8161565. DOI: 10.1186/s12941-021-00442-x. View

11.

Carvalho T, McConville J . The function and performance of aqueous aerosol devices for inhalation therapy. J Pharm Pharmacol. 2016; 68(5):556-78. DOI: 10.1111/jphp.12541. View

12.

McCarrel T . Equine Platelet-Rich Plasma. Vet Clin North Am Equine Pract. 2023; 39(3):429-442. DOI: 10.1016/j.cveq.2023.06.007. View

13.

Ferri M, Ranucci E, Romagnoli P, Giaccone V . Antimicrobial resistance: A global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2015; 57(13):2857-2876. DOI: 10.1080/10408398.2015.1077192. View

14.

Rios D, Lopez C, Carmona J . Platelet-Rich Gel Supernatants Stimulate the Release of Anti-Inflammatory Proteins on Culture Media of Normal Equine Synovial Membrane Explants. Vet Med Int. 2015; 2015:547052. PMC: 4451761. DOI: 10.1155/2015/547052. View

15.

Kimura S, McCoy A, Boothe D, Wooldridge A, Graff E, Hammack S . Effects of a single dose of orally and rectally administered misoprostol in an in vivo endotoxemia model in healthy adult horses. Am J Vet Res. 2022; 83(8). DOI: 10.2460/ajvr.21.12.0206. View

16.

Burnouf T, Chou M, Wu Y, Su C, Lee L . Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. Transfusion. 2012; 53(1):138-46. DOI: 10.1111/j.1537-2995.2012.03668.x. View

17.

Pennati A, Apfelbeck T, Brounts S, Galipeau J . Washed Equine Platelet Extract as an Anti-Inflammatory Biologic Pharmaceutical. Tissue Eng Part A. 2020; 27(9-10):582-592. DOI: 10.1089/ten.TEA.2020.0160. View

18.

Carvalho T, Peters J, Williams 3rd R . Influence of particle size on regional lung deposition--what evidence is there?. Int J Pharm. 2011; 406(1-2):1-10. DOI: 10.1016/j.ijpharm.2010.12.040. View

19.

Moojen D, Everts P, Schure R, Overdevest E, van Zundert A, Knape J . Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2007; 26(3):404-10. DOI: 10.1002/jor.20519. View

20.

Strandberg G, Sellberg F, Sommar P, Ronaghi M, Lubenow N, Knutson F . Standardizing the freeze-thaw preparation of growth factors from platelet lysate. Transfusion. 2017; 57(4):1058-1065. DOI: 10.1111/trf.13998. View